Last reviewed · How we verify

Administration of Azithromycin on Day 15

London School of Hygiene and Tropical Medicine · FDA-approved active Small molecule Quality 2/100

Administration of Azithromycin on Day 15 is a Small molecule drug developed by London School of Hygiene and Tropical Medicine. It is currently FDA-approved.

At a glance

Generic nameAdministration of Azithromycin on Day 15
SponsorLondon School of Hygiene and Tropical Medicine
ModalitySmall molecule
PhaseFDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Administration of Azithromycin on Day 15

What is Administration of Azithromycin on Day 15?

Administration of Azithromycin on Day 15 is a Small molecule drug developed by London School of Hygiene and Tropical Medicine.

Who makes Administration of Azithromycin on Day 15?

Administration of Azithromycin on Day 15 is developed and marketed by London School of Hygiene and Tropical Medicine (see full London School of Hygiene and Tropical Medicine pipeline at /company/london-school-of-hygiene-and-tropical-medicine).

What development phase is Administration of Azithromycin on Day 15 in?

Administration of Azithromycin on Day 15 is FDA-approved (marketed).

Related